Louisiana SB30 prohibits state agencies and licensing boards from restricting telehealth use for obesity treatment.
Louisiana SB30 enacts a provision to prevent state agencies and licensing boards from prohibiting or restricting licensed healthcare providers from using telehealth to evaluate, diagnose, or treat obesity or related metabolic conditions. This includes the prescription of FDA-approved or compounded noncontrolled medication, provided the healthcare provider acts within the scope of their license and in accordance with the applicable standard of care. The law also mandates that these agencies and boards promulgate rules to promote and regulate the use of telehealth in healthcare delivery.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.